Compounds > 2-isopropylaminoethanol
Page last updated: 2024-09-21

2-isopropylaminoethanol

Description

2-isopropylaminoethanol: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7994
SCHEMBL ID143017
MeSH IDM0051845

Synonyms (50)

Synonym
EN300-21840
2-[(propan-2-yl)amino]ethan-1-ol
2-(isopropylamino)-ethanol
nsc-128124
nsc128124
einecs 203-681-4
brn 1633453
nsc 1090
ai3-24220
ethanol, 2-((1-methylethyl)amino)-
2-isopropylamino ethanol
2-((1-methylethyl)amino)ethanol
isopropylaminoethanol
109-56-8
n-isopropylaminoethanol
nsc1090
monoisopropylaminoethanol
ethanol, 2-(isopropylamino)-
PAE ,
(n-hydroxyethyl)isopropylamine
nsc-1090
ethanolisopropylamine
n-isopropylethanolamine
2-isopropylaminoethanol
ethanol, 2-[(1-methylethyl)amino]-
2-(isopropylamino)ethanol, 70%
AKOS000245054
2-(propan-2-ylamino)ethanol
2-(isopropylamino)ethanol
I0227
A802053
y8l7kc6hub ,
unii-y8l7kc6hub
3-04-00-00681 (beilstein handbook reference)
FT-0612715
2-isopropylamino-ethanol
isopropyl-2-hydroxyethyl amine
2-(1-methylethylamino)ethanol
2-(isopropylamino)ethan-1-ol
SCHEMBL143017
DTXSID5059373
2-isopropyl amino ethanol
J-002307
F2190-0354
mfcd00041755
Z137800940
FS-4683
D78491
SB83859
SY051346

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
isoproterenol[no description available]medium80catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
histamine[no description available]medium20aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
clorprenaline[no description available]medium30ethanolamines;
monochlorobenzenes;
secondary amino compound
tartaric acid[no description available]medium10tartaric acidEscherichia coli metabolite
dichloroisoproterenol[no description available]medium10
metaproterenol[no description available]medium20aralkylamino compound;
phenylethanolamines;
resorcinols;
secondary alcohol;
secondary amino compound
indopan[no description available]medium10tryptamines
catechol[no description available]medium10catecholsallelochemical;
genotoxin;
plant metabolite
lysergic acid diethylamide[no description available]medium10ergoline alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound		dopamine agonist;
hallucinogen;
serotonergic agonist
phencyclidine[no description available]medium10benzenes;
piperidines		anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
tretinoin[no description available]medium10retinoic acid;
vitamin A		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
contraceptives, postcoital[no description available]medium10
ConditionIndicatedRelationship StrengthStudiesTrials
Abscess, Pulmonary0low10
Abscesses, Pulmonary0low10
Asthma0low60
Asthma, Bronchial0low60
Blood Pressure, High0low10
Blood Pressure, Low0low10
Bronchial Asthma0low60
Bronchitis0low10
Bronchitis, Chronic0low10
Chronic Bronchitis0low10
Glaucoma0low10
Hypertension0low10
Hypotension0low10
Hypotension, Vascular0low10
Low Blood Pressure0low10
Lung Abscess0low10
Pulmonary Abscess0low10
Pulmonary Abscesses0low10
Vascular Hypotension0low10